Description
In Neurology it is indicated in patients with clinically uncertain parkinsonian syndromes, to differentiate essential tremor from parkinsonian syndromes related to degenerative diseases affecting the nigrostriatal system.
In oncoimaging applications it allows a functional approach to intracellular transport and decarboxylation of the amino acid dihydroxyphenylalanine (diagnosis and localization of insulinoma in cases of hyperinsulinism, glomus tumors, localization and staging of pheochromocytomas and paragangliomas, TEG when somatostatin receptor scintigraphy is negative, etc.).
Category: BIOMARKER
Sub - Category: Diagnostic product for “in vivo” use”
![3’-deoxi-[<sup>18</sup>F]-fluorotimidina (<sup>18</sup>F-FLT) solución.](https://tecnonuclear.com/wp-content/uploads/2025/12/ffly-300x300.jpg)
